Skip to content

CG Oncology CGON Common Stock

Common Stock at other companies

ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
1.7B+22.2%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$171K+50.0%
Tango Therapeutics logo
Tango TherapeuticsTNGX
400M+100%
Celcuity logo
CelcuityCELC
95M0.0%
Immunovant, Inc. logo
Immunovant, Inc.IMVT
$20K+25.0%
Summit Therapeutics logo
Summit TherapeuticsSMMT
1B0.0%

Other financials

Income statement

See full
Revenue$1.1M+1,983%
Operating income-$66.4M-57.3%
Net income-$60.2M-74.7%
EPS (diluted)-$0.71-57.8%

Balance sheet

See full
Cash & equivalents$33.7M-18.7%
Total debt$7.6M+631%
Total equity$1.1B+54.9%
Total assets$1.1B+55.9%

Cash flow

See full
Operating cash flow-$56.9M-94.5%
CapEx$304.0K+1,800%
Free cash flow-$57.2M-95.4%

Valuation

See full
Market cap$5.39B+206%

Profitability

See full
Operating margin-4,239%-1,872pp
Net margin-3,682.6%-1,601pp
FCF margin-3,163.8%-1,351pp

Returns & leverage

See full
Return on equity-20.8%+7.1pp
Debt / equity0.0×
Current ratio31.3×+0.3×

Where this comes from

Reported directly by CG Oncology in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about CG Oncology's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CG Oncology's common stock?
CG Oncology (CGON) reported common stock of $9K in Q1 2026.
How has CG Oncology's common stock changed year-over-year?
CG Oncology's common stock increased by 12.5% year-over-year, from $8K to $9K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).